Protalix BioTherapeutics Analyst Ratings
Protalix BioTherapeutics Analyst Ratings
While ratings are subjective and will change, the latest Protalix BioTherapeutics (PLX) rating was a maintained with a price target of $7.00 to $10.00. The current price Protalix BioTherapeutics (PLX) is trading at is $1.45, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/31/2023 | 589.66% | HC Wainwright & Co. | $7 → $10 | Maintains | Buy |
| 05/03/2021 | 382.76% | HC Wainwright & Co. | $11 → $7 | Maintains | Buy |
| 06/08/2020 | 658.62% | HC Wainwright & Co. | $3 → $11 | Maintains | Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 10/31/2023 | 589.66% | HC Wainwright & Co. | 7 美元 → 10 美元 | 维护 | 买 |
| 05/03/2021 | 382.76% | HC Wainwright & Co. | 11 美元 → 7 美元 | 维护 | 买 |
| 06/08/2020 | 658.62% | HC Wainwright & Co. | 3 美元 → 11 美元 | 维护 | 买 |
What is the target price for Protalix BioTherapeutics (PLX)?
Protalix BioTherapeutics（PLX）的目标价格是多少？
The latest price target for Protalix BioTherapeutics (AMEX: PLX) was reported by HC Wainwright & Co. on October 31, 2023. The analyst firm set a price target for $10.00 expecting PLX to rise to within 12 months (a possible 589.66% upside). 1 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2023年10月31日公布了Protalix BioTherapeutics（美国证券交易所股票代码：PLX）的最新目标价格。该分析公司将目标股价定为10.00美元，预计PLX将在12个月内升至12个月内（可能上涨589.66％）。1家分析公司去年公布了评级。
What is the most recent analyst rating for Protalix BioTherapeutics (PLX)?
Protalix BioTherapeutics（PLX）的最新分析师评级是多少？
The latest analyst rating for Protalix BioTherapeutics (AMEX: PLX) was provided by HC Wainwright & Co., and Protalix BioTherapeutics maintained their buy rating.
HC Wainwright & Co. 提供了Protalix BioTherapeutics（美国证券交易所股票代码：PLX）的最新分析师评级，Protalix BioTherapeutics维持买入评级。
When is the next analyst rating going to be posted or updated for Protalix BioTherapeutics (PLX)?
Protalix BioTherapeutics（PLX）的下一次分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Protalix BioTherapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Protalix BioTherapeutics was filed on October 31, 2023 so you should expect the next rating to be made available sometime around October 31, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Protalix BioTherapeutics的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月做一次这样的评级，因此每家公司每年应该获得4次评级。Protalix BioTherapeutics的最新评级是在2023年10月31日公布的，因此您应该预计下一个评级将在2024年10月31日左右公布。
Is the Analyst Rating Protalix BioTherapeutics (PLX) correct?
分析师对Protalix BioTherapeutics（PLX）的评级是否正确？
While ratings are subjective and will change, the latest Protalix BioTherapeutics (PLX) rating was a maintained with a price target of $7.00 to $10.00. The current price Protalix BioTherapeutics (PLX) is trading at is $1.45, which is out of the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但最新的Protalix BioTherapeutics（PLX）评级维持不变，目标股价为7.00美元至10.00美元。Protalix BioTherapeutics（PLX）目前的交易价格为1.45美元，超出了分析师的预期区间。
译文内容由第三方软件翻译。
